Sanofi, BioNTech sign cancer treatment partnership

November 3, 2015 6:12 AM

25 0

PARIS Nov 3 Sanofi and BioNTech said they signed a collaboration and licence agreement to discover and develop up to five cancer immunotherapies, the companies said in a statement on Tuesday.

BioNTech will receive $60 million in upfront and near-term milestone payments and could receive over $300 million in development, regulatory and commercial milestones and other payments per product, the companies said.

Also read: FDA OKs 2nd gene therapy for blood cancer; 1st for adults

Read more

To category page